UC BON.CAP.CERT. 03/25 COK/ DE000HD41SD4 /
12/06/2024 11:45:41 | Var.+0.010 | Denaro11:55:24 | Lettera11:55:24 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
36.640EUR | +0.03% | 36.640 Quantità in denaro: 3,000 |
36.680 Quantità in lettera: 3,000 |
CANCOM SE O.N. | - - | 28/03/2025 | Call |
GlobeNewswire
11:55
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugat...
Newsfile Corp
11:09
Recent Survey Conducted by Printblur Unveils Trends in Millennial Father Consumer Segment
GlobeNewswire
11:00
Pulsar Invites Shareholders to View New Presentation at Emerging Growth Conference
GlobeNewswire
11:00
Point Survey: 67% of Homeowners Say it’s Difficult to Keep Up with Monthly Expenses
GlobeNewswire
11:00
Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO...
GlobeNewswire
10:59
Early Signals by WOO X: Bitcoin Hits Key Support, Artrade NFT Marketplace Surges
GlobeNewswire
10:30
Copenhagen Infrastructure Partners Announces Greengate Biogas Partnership in Ireland
GlobeNewswire
10:00
Intech Unveils UCITS Fund with Adaptive Volatility and ESG Focus, Anchored by Norway’s Pension Schem...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated...
GlobeNewswire
10:00
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation I...